(2023)
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer.
BREAST.
72,
(2023)
Incidence of and Influencing Factors for Arm Lymphedema After Salvage Treatment for an Isolated Locoregional Recurrence of Breast Cancer.
JOURNAL OF BREAST CANCER.
26,
6
(2023)
The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer.
CANCERS.
15,
22
(2023)
The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis.
CANCERS.
15,
22
(2023)
Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study.
FRONTIERS IN ONCOLOGY.
13,
(2023)
Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy.
WORLD JOURNAL OF CLINICAL CASES.
11,
27
(2023)
Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis.
JMIR PUBLIC HEALTH AND SURVEILLANCE.
9,
1
(2023)
Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer.
EXPERIMENTAL AND MOLECULAR MEDICINE.
55,
7
(2023)
Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study.
CANCERS.
15,
13
(2023)
Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study.
ANNALS OF SURGICAL TREATMENT AND RESEARCH.
105,
1
(2023)
Impact of Adjuvant Hormone Therapy on Sleep, Physical Activity, and Quality of Life in Premenopausal Breast Cancer: 12-Month Observational Study.
JOURNAL OF BREAST CANCER.
26,
2
(2023)
The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial.
FRONTIERS IN ONCOLOGY.
13,
(2023)
Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis.
CANCERS.
15,
5
(2023)
Feasibility and usability of a personalized mHealth app for self-management in the first year following breast cancer surgery.
HEALTH INFORMATICS JOURNAL.
29,
1
(2022)
Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay.
JOURNAL OF BREAST CANCER.
25,
6
(2022)
Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?.
JOURNAL OF CLINICAL MEDICINE.
11,
21
(2022)
Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/ Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience.
CANCER RESEARCH AND TREATMENT.
54,
4
(2022)
Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort.
CANCERS.
14,
19
(2022)
Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/nipple-sparing mastectomy.
BREAST.
66,
(2022)
Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma.
Journal of Breast Cancer.
25,
4
